GLP-1 Side Effects: Common Reactions and When to Seek Advice

• Understand why GI side effects vary so much between individuals, and what genuinely reduces them (it isn't which brand you pick)
• See the common, less common and rare reactions, and exactly when each needs medical advice
• Learn how dose titration is used specifically to manage GI tolerability
• Find out how to report a side effect and what your prescriber can adjust if symptoms don't settle

Have you started a GLP-1 medicine and suddenly found that your stomach is behaving differently? Nausea, constipation, diarrhoea and vomiting are some of the side effects people may notice, particularly when treatment starts or the dose goes up.

For most people, these symptoms are mild to moderate and may become easier to manage as the body adjusts. However, some symptoms need medical attention, especially if they are severe, persistent or linked to dehydration.

There is also no simple answer to which GLP-1 medicine causes the fewest stomach related side effects. Different medicines have been studied in different groups of people and at different doses, so comparing percentages from separate trials does not reliably tell you which medicine will be easier on your stomach.

This guide looks at why these side effects happen, what you can do if they occur, how dose increases are usually managed, and when it is important to contact a healthcare professional.

Key things to know

• Nausea, vomiting, diarrhoea and constipation are among the most commonly reported side effects of GLP-1 medicines and related medicines such as tirzepatide.
• GI side effects are often more noticeable when treatment starts or the dose is increased. They may become less noticeable as your body adjusts to the medicine.
• There is no reliable UK evidence that can rank these medicines from the fewest to the most GI side effects. Individual responses can be very different.
• Gradual dose increases are used to help improve tolerability. If you are having significant symptoms, your prescriber may delay an increase or adjust your treatment.
• Vomiting and diarrhoea can cause dehydration. This can sometimes lead to more serious problems, including kidney problems, so keeping fluids up is important.
• Severe, persistent abdominal pain, particularly if it spreads to your back, needs urgent medical attention because it can be a sign of acute pancreatitis.
• You can report suspected side effects through the MHRA Yellow Card scheme, even if the reaction is not listed in your medicine's information leaflet.

Which GLP-1 Has the Least GI Side Effects?

If you are worried about nausea or stomach problems, it is understandable to wonder whether one medicine is easier to tolerate than another.

At present, there is no reliable UK evidence that allows GLP-1 medicines to be ranked by GI tolerability. Medicines such as semaglutide and tirzepatide have their own clinical trial data, but those trials can involve different doses, treatment periods and groups of people. Comparing the numbers directly can therefore give a misleading impression.

Why can the experience be so different?

Two people taking the same medicine at the same dose can have very different experiences. One person may have mild nausea for a few days, while another may find constipation or diarrhoea more troublesome.

The dose also matters. For example, the current product information for injectable semaglutide and tirzepatide states that GI reactions are more common during dose escalation and tend to decrease over time.

That is why choosing a medicine should not be based simply on claims that one option is "gentler" on the stomach. Your medical history, other medicines, treatment goals and how you respond to the medicine all matter.

Why Do GLP-1 Medicines Cause GI Side Effects?

Your digestive system is one of the places where these medicines have an effect, so it is not surprising that the stomach and bowel can notice the change.

GLP-1 receptor agonists can slow gastric emptying, meaning food can move out of the stomach more slowly. This can contribute to feeling full for longer, but it can also cause symptoms such as nausea, fullness and vomiting.

Tirzepatide works on both the GLP-1 and GIP receptors, so it is not technically a GLP-1 receptor agonist alone. It can also cause GI side effects such as nausea, diarrhoea, vomiting and constipation.

These effects are often more noticeable when a medicine is started or when the dose is increased. For many people, they become less troublesome once they have been on the same dose for a while.

Common Side Effects and What May Help

Not every person will experience the same side effects, and you may not experience all of these.

The product information for semaglutide and tirzepatide lists nausea, vomiting, diarrhoea and constipation among their GI adverse reactions. The exact frequency varies between medicines, doses and clinical studies.

Nausea and vomiting

Feeling sick is one of the side effects people commonly report, especially during the early stages of treatment or after a dose increase.

Try smaller meals and eat slowly rather than pushing yourself to finish a meal when you already feel full. Rich or high fat meals may also feel harder to tolerate.

If you are vomiting repeatedly, cannot keep fluids down or feel dizzy or unusually weak, do not simply wait for it to pass. Contact your prescriber or seek medical advice, as vomiting can lead to dehydration.

Diarrhoea and constipation

GLP-1 medicines can affect bowel movements in different ways. Some people experience diarrhoea, while others become constipated. It is also possible for bowel symptoms to change at different stages of treatment.

If you have diarrhoea, replacing lost fluids is important. If constipation continues despite simple measures such as adequate fluids and fibre, speak to your prescriber or pharmacist.

Reduced appetite, fullness and indigestion

A lower appetite is an expected effect of many medicines in this group and is part of how they can support weight management.

However, there is a difference between feeling less hungry and struggling to eat or drink because you feel unwell. If you are eating very little, regularly feel uncomfortably full, or have ongoing indigestion, mention it at your next review.

Dose Titration: Why Your Dose May Increase Slowly

There is a reason these medicines are not usually started at their full maintenance dose.

Dose titration means starting with a lower dose and increasing it gradually. The schedules differ between medicines, but gradual increases are used to help the body adjust and reduce the likelihood or severity of GI symptoms.

For example, injectable semaglutide is gradually increased over several weeks. If significant GI symptoms occur, its current product information says that delaying the next increase or returning to the previous dose can be considered until symptoms improve.

Tirzepatide is also increased in stages, with at least four weeks at each dose before a further increase is considered.

The important point is that you should not change the dose yourself. If side effects are making treatment difficult, tell your prescriber. They can decide whether you should stay at the current dose for longer, reduce the dose or consider another option.

What Your Prescriber May Check During Treatment

You do not have to wait until a planned appointment to mention side effects that are bothering you.

During treatment, your prescriber may ask about nausea, vomiting, bowel changes, abdominal pain, appetite and how well you are managing the current dose. They may also review other medicines you take and any health conditions that could affect your treatment.

How often you have a review depends on the medicine, your treatment plan and how you are responding. There is not one review schedule that applies to everyone.

Keeping a simple note of when symptoms happen can be useful. For example, you could record whether symptoms started after a dose increase, how long they lasted and whether you were able to eat and drink normally. This gives your prescriber something practical to work with.

If you are also monitoring your weight loss, remember that changes do not always happen at the same pace throughout treatment.

Practical Things That May Make GI Side Effects Easier

You do not need to completely change your diet because of a GLP-1 medicine. Small changes may be enough to make meals more comfortable while your body adjusts.

• Eat slowly and stop when you feel comfortably full.
• Try smaller meals if large meals make you feel sick or overly full.
• Avoid very rich or high fat meals if you notice that they make your symptoms worse.
• Drink fluids regularly, particularly if you have vomiting or diarrhoea.
• If constipation is a problem, make sure you are getting enough fluid and fibre unless a healthcare professional has advised you to limit either.
• If a particular food repeatedly makes your symptoms worse, make a note of it and discuss it with your prescriber or pharmacist.

These suggestions are not a substitute for medical advice. If symptoms are severe, persistent or affecting your ability to eat and drink, speak to a healthcare professional rather than trying to manage them yourself.

Who May Need Extra Care With GI Side Effects?

Some people may need closer monitoring when taking these medicines.

Tell your prescriber if you have a history of pancreatitis or significant problems affecting your stomach or digestion. For example, the product information for tirzepatide advises caution in people with a history of pancreatitis and in people with severe gastrointestinal disease.

People with kidney problems may also need particular care if vomiting or diarrhoea occurs because loss of fluids can affect kidney function.

This does not automatically mean that you cannot use a GLP-1 medicine. It means your prescriber needs to consider your individual circumstances before deciding what is appropriate.

Less Common and Serious Reactions

Most GI side effects are not serious, but it is important to know which symptoms should not be ignored.

Gallbladder problems

Gallstones and other gallbladder problems have been reported with medicines such as tirzepatide.

Seek medical advice if you develop severe or persistent pain in the upper right part of your abdomen, particularly if it occurs with fever, vomiting or yellowing of the skin or eyes.

Acute pancreatitis

Acute pancreatitis is an infrequent but potentially serious reaction associated with GLP-1 medicines and related medicines such as tirzepatide. The MHRA advises patients to be alert for severe, persistent stomach pain that may spread to the back and may occur with nausea or vomiting.

If you develop this type of pain, seek urgent medical help rather than waiting to see whether it settles.

Serious allergic reactions

A serious allergic reaction can cause symptoms such as swelling of the face, lips, mouth or throat, difficulty breathing, or a severe skin reaction.

If you have difficulty breathing or swelling of the mouth or throat, seek emergency medical help immediately.

Dehydration from vomiting or diarrhoea

Vomiting and diarrhoea may be common side effects, but losing too much fluid can become a more serious problem.

Watch for symptoms such as dizziness, unusual weakness, a very dry mouth or passing much less urine than usual. Severe or prolonged vomiting or diarrhoea needs medical advice, particularly if you cannot keep fluids down.

Injectable vs Oral GLP-1 Medicines: Does the Form Matter?

Not all medicines in this group are injections. Semaglutide is now available in both injectable and oral forms in the UK, while the exact instructions depend on the product you have been prescribed.

Oral semaglutide has specific instructions because the way you take the tablet affects how much medicine your body absorbs. The current UK product information states that the tablet should be taken as directed, with a wait of at least 30 minutes before eating, drinking or taking other oral medicines.

The injectable and oral forms can both cause GI side effects. There is not enough evidence to say that choosing a tablet instead of an injection will reliably mean fewer stomach related problems.

If you are considering changing from one form to another, speak to your prescriber rather than changing the treatment yourself.

When to Seek Medical Advice

Most nausea, constipation, diarrhoea and vomiting can be managed with advice from your prescriber or pharmacist. However, some symptoms need more urgent attention.

Seek urgent medical help if you develop:

• Severe or persistent abdominal pain, particularly if it spreads to your back.
• Severe or prolonged vomiting or diarrhoea, especially if you cannot keep fluids down or have signs of dehydration.
• Swelling of the face, lips, mouth or throat, or difficulty breathing.
• Yellowing of the skin or eyes, particularly with abdominal pain or feeling unwell.
• Severe or worsening pain in the upper right side of your abdomen, particularly with fever.

The MHRA advises that suspected side effects can also be reported through the Yellow Card scheme. Reporting helps regulators monitor the safety of medicines after they are in wider use.

Medical Disclaimer

This article is for general information only and does not replace individual medical advice.

GLP-1 medicines and related medicines such as tirzepatide are prescription medicines. Whether a particular treatment is suitable for you depends on your health, other medicines, medical history and individual circumstances.

Do not change your dose or stop treatment because of a side effect without speaking to your prescriber, unless you are experiencing symptoms that require urgent medical help. Always read the patient information leaflet supplied with your medicine.